Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 69123-98-4, Fiau, Fluoroiodoarauridine, 1-(2-deoxy-2-fluoro-b-d-arabinofuranosyl)-5-iodouracil, 53t7in77lc, 1-(2'fluoro-2'-deoxyarabinofuranosyl)-5-iodouracil
Molecular Formula
C9H10FIN2O5
Molecular Weight
372.09  g/mol
InChI Key
IPVFGAYTKQKGBM-BYPJNBLXSA-N
FDA UNII
53T7IN77LC

Fialuridine is a nucleoside analog of uridine with activity against hepatitis B virus and herpes viruses. Fialuridine inhibits viral DNA polymerase and viral replication.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione
2.1.2 InChI
InChI=1S/C9H10FIN2O5/c10-5-6(15)4(2-14)18-8(5)13-1-3(11)7(16)12-9(13)17/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5+,6-,8-/m1/s1
2.1.3 InChI Key
IPVFGAYTKQKGBM-BYPJNBLXSA-N
2.1.4 Canonical SMILES
C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I
2.1.5 Isomeric SMILES
C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F)I
2.2 Other Identifiers
2.2.1 UNII
53T7IN77LC
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(2'fluoro-2'-deoxyarabinofuranosyl)-5-iodouracil

2. 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo-2,4(1h,3h)-pyrimidinedione

3. 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo-unracil

4. 123i-fiau

5. 2'-fluoro-5-iodoarauracil

6. Fiau

2.3.2 Depositor-Supplied Synonyms

1. 69123-98-4

2. Fiau

3. Fluoroiodoarauridine

4. 1-(2-deoxy-2-fluoro-b-d-arabinofuranosyl)-5-iodouracil

5. 53t7in77lc

6. 1-(2'fluoro-2'-deoxyarabinofuranosyl)-5-iodouracil

7. 1-[(2r,3s,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione

8. Nsc-678514

9. 1-((2r,3s,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1h,3h)-dione

10. Drg-0098

11. 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodouracil

12. Fialuridine [usan:inn]

13. Unii-53t7in77lc

14. Mfcd00866922

15. 2'-fluoro-5-iodo-1-beta-d-arabinofuranosyluracil

16. Uracil, 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo-

17. Fialuridine [mi]

18. 2'-fluoro-5-iodouracil

19. Fialuridine [inn]

20. 5-iodo-2-fluoroarauracil

21. Fialuridine (usan/inn)

22. Fialuridine [usan]

23. Schembl3189

24. 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo-2,4(1h,3h)-pyrimidinedione

25. 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo-

26. Fialuridine [mart.]

27. 1-(2-deoxy-2-fluoro-.beta.-d-arabinofuranosyl)-5-iodouracil

28. Chembl271475

29. Fialuridine, >=98% (hplc)

30. Dtxsid701028030

31. Zinc4216113

32. Bdbm50367488

33. Akos015856198

34. Akos016009483

35. Db15427

36. Nsc 678514

37. 1-[(2r,3s,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione

38. Ac-32361

39. As-69583

40. Hy-118122

41. Cs-0065233

42. D04181

43. F12931

44. 691f984

45. A848801

46. J-700174

47. J-700352

48. Q5446286

49. 1-(2-deoxy-2-fluoro--d-arabinofuranosyl)-5-iodouracil

50. 1-(2'-deoxy-2'-fluoro-.beta.-d-arabinofuranosyl)-5-iodouracil

51. 1-(2'-deoxy-2'-fluoro-b-d-arabinofuranosyl)-5-iodouracil

52. 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-.beta.-d-arabinofuranosyl)-5-iodo-

53. 1-((2s,3r,4s,5s)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1h,3h)-dione

54. 1-[(2r,3s,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione

2.4 Create Date
2005-08-01
3 Chemical and Physical Properties
Molecular Weight 372.09 g/mol
Molecular Formula C9H10FIN2O5
XLogP3-0.9
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count2
Exact Mass371.96185 g/mol
Monoisotopic Mass371.96185 g/mol
Topological Polar Surface Area99.1 Ų
Heavy Atom Count18
Formal Charge0
Complexity418
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


Nucleic Acid Synthesis Inhibitors

Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)